Works matching IS 15228517 AND DT 2024 AND VI 26 AND IP 10
Results: 18
Society News: Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1948, doi. 10.1093/neuonc/noae159
- Publication type:
- Article
Corrigendum to: LY6K promotes glioblastoma tumorigenicity via CAV-1–mediated ERK1/2 signaling enhancement.
- Published in:
- 2024
- Publication type:
- Correction Notice
Temozolomide use in elderly patients with MGMT promoter unmethylated glioblastoma: Is it finally time to dismount a dead horse?
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1876, doi. 10.1093/neuonc/noae143
- By:
- Publication type:
- Article
Tools and toys beyond RANO 2.0: Digital flipbooks to monitor brain tumor growth dynamics?
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1837, doi. 10.1093/neuonc/noae141
- By:
- Publication type:
- Article
Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1781, doi. 10.1093/neuonc/noae103
- By:
- Publication type:
- Article
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1839, doi. 10.1093/neuonc/noae102
- By:
- Publication type:
- Article
Erratum to: QOL-14. EPILEPTIC SEIZURES, ANTI-SEIZURE MEDICATIONS, AND NEUROCOGNITION IN SURVIVORS OF PEDIATRIC BRAIN TUMORS.
- Published in:
- 2024
- Publication type:
- Correction Notice
IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β-mediated immune suppression and potentiate anti-tumor responses in glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1850, doi. 10.1093/neuonc/noae126
- By:
- Publication type:
- Article
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1895, doi. 10.1093/neuonc/noae120
- By:
- Publication type:
- Article
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1912, doi. 10.1093/neuonc/noae114
- By:
- Publication type:
- Article
Genome-wide polygenic risk scores predict risk of glioma and molecular subtypes.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1933, doi. 10.1093/neuonc/noae112
- By:
- Publication type:
- Article
Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1878, doi. 10.1093/neuonc/noae109
- By:
- Publication type:
- Article
No benefit from TMZ treatment in glioblastoma with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patients.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1867, doi. 10.1093/neuonc/noae108
- By:
- Publication type:
- Article
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1805, doi. 10.1093/neuonc/noae107
- By:
- Publication type:
- Article
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1742, doi. 10.1093/neuonc/noae082
- By:
- Publication type:
- Article
Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumors.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1823, doi. 10.1093/neuonc/noae097
- By:
- Publication type:
- Article
Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recovery.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1921, doi. 10.1093/neuonc/noae091
- By:
- Publication type:
- Article
Expression of Concern: microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.
- Published in:
- 2024
- Publication type:
- Correction Notice